Royalty Will Go No Higher In Bid For Elan, Citing J&J Sell-Off
Royalty Pharma Inc. on Thursday refused to raise its $11.25-per-share hostile bid for Elan Corp. PLC, noting that Johnson & Johnson tendered nearly its entire stake in the Irish drugmaker at...To view the full article, register now.
Already a subscriber? Click here to view full article